Articles

The association was also found to be stronger in younger women than in older women… Data from a large ongoing study into the health of African-American women show that those who work night shifts are significantly more likely to develop diabetes than those who have never worked night shifts, with …

Anemia is higher in older type 2 diabetes patients… The chances of an anemia diagnosis increase with age and it affects roughly about 10% of those 65 years of age or older. In diabetes patients, the probability of diagnosing anemia could be two to threefold higher and furthermore, from previous …

The new drug apparently works by stabilizing metabolites of an omega-3 fatty acid called DHA… Researchers Bruce Hammock at the University of California, Davis, and Joan Claria at the University of Barcelona found that an enzyme called soluble epoxide hydrolase, or sEH, inhibitor both prevented the onset of diabetes and …

Hypoglycemia was relatively uncommon in the ORIGIN (Outcome Reduction with an Initial Glargine Intervention) trial… ORIGIN trial investigators have published results of their look at treatment with insulin glargine compared with standard care early in the course of dysglycemia, and its effects on hypoglycemia. A total of 12,537 people with …

A longer duration of obesity also increased risk of colorectal cancer for diabetic patients… Dutch researchers have assessed the risk of colorectal cancer associated with type 2 diabetes, as compared with a nondiabetic reference population. They conducted an observational population-based cohort study within the Clinical Practice Research Datalink (1987–2012). All …

A new combination of two FDA-approved drugs has shown a remarkable 8.7% average weight loss and a reduction of 1 point for A1c in just 12 weeks…

Glargine 300 more effective than glargine 100 currently available… Two single-dose studies were conducted in Japan and Europe to compare the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of new insulin glargine 300 U/ml (Gla-300) and insulin glargine 100 U/ml (Gla-100) in people with type 1 diabetes mellitus. In two double-blind, randomized, crossover …

The GLP-1 agonist albiglutide was added to the regimen of patients already on metformin and glimepiride…

But the effects are modest and type 2 patients on metformin can do moderate exercise without undue fear of hypoglycemia… Before, during, and after a 45-min bout of exercise at 60% VO2max, glucose kinetics were determined by isotope tracer technique in patients with type 2 diabetes mellitus with metformin treatment …

Can metformin reduce the risk of cancer for those with type 2 diabetes?… In previous studies, metformin has been shown to decrease the risk of cancer in type 2 diabetes. A recent meta-analysis showed a 34% reduction in the incidence of any cancer and a 33% reduction in cancer mortality; …